The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus.

Cardiovasc Drugs Ther · 2022 · PMC9090862 · PMID 34750713

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the impact on reinfarction and stroke was similar to that of sotagliflozin in SCORED and SOLOIST [ 5 , 6 ], patients in this observational study were early post MI and at a high risk of recurrent MI and stroke, and the effects did not reach statistical significance [ 16 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.